Infographic
A lifecycle approach to the use of RWE in HTA submissions and re-submissions, a decade's experience
HTAi Conference
Jul 01, 2022
Download

Health Technology Assessment (HTA) bodies worldwide recognize the importance of real-world evidence (RWE) in addressing uncertainties around the effectiveness of new drugs at time of launch and in reassessments. In recent years, we have witnessed the emergence of frameworks in support of the use of RWE Did you attend the RWE session on HTAi last week? If you are interested to learn more, you can find here the poster presented by our experts at the conference or request a trial access: https://www.iqvia.com/form-pages/demo

Related solutions

Contact Us